In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the ...

The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Researchers reveal a strategy that helps medulloblastoma, the most prevalent malignant brain tumor in children, spread and grow on the leptomeninges, the membranes surrounding the brain and spinal ...

In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Despite promising glioblastoma trial results, Northwest Biotherapeutics faces financial instability, heavy dilution, and an ...

New insights into the mechanisms that cause more severe cases of schistosomiasis - a disease caused by parasitic worms and ...

Vaccinex (VCNX) will present exciting new data characterizing the unique mechanism of pepinemab to enhance immune responses to checkpoint ...

With 26.6% of the European market share in 2022, the U.K. is recognized as a lucrative market for cell therapy manufacturing. Support from regulatory bodies like the European Medicines Agency (EMA) ...